Tyra Biosciences Analyst Ratings
Piper Sandler Initiates TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $33
Buy Rating for Tyra Biosciences Backed by TYRA-300's Potential and FGFR Expertise
Oppenheimer Reiterates Outperform on Tyra Biosciences, Maintains $28 Price Target
Tyra Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $23 Price Target
Tyra Biosciences Analyst Ratings
Oppenheimer: Reiterated the Tyra Biosciences (TYRA.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $25.00 to $28.00.
Tyra Biosciences Analyst Ratings
Oppenheimer Reiterates Outperform on Tyra Biosciences, Raises Price Target to $28
Tyra Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $23 Price Target
HC Wainwright & Co. : The Tyra Biosciences (TYRA.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $23.00.
Tyra Biosciences Analyst Ratings
Tyra Biosciences Analyst Ratings
Tyra Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $19 Price Target
Tyra Biosciences Analyst Ratings
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $19
Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $27 Price Target